Teza Capital Management LLC Makes New $1.03 Million Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Teza Capital Management LLC purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 44,496 shares of the company's stock, valued at approximately $1,032,000.

Other hedge funds have also modified their holdings of the company. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health in the fourth quarter worth $26,000. UMB Bank n.a. increased its position in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares during the last quarter. Signaturefd LLC increased its position in Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after buying an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC increased its position in Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after buying an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in Option Care Health during the fourth quarter worth $47,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

OPCH has been the topic of several analyst reports. JMP Securities reissued a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. Finally, UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $35.50.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is currently owned by insiders.

Option Care Health Price Performance

OPCH traded down $0.62 during midday trading on Friday, reaching $31.41. 836,498 shares of the company's stock were exchanged, compared to its average volume of 1,862,931. The firm has a market capitalization of $5.14 billion, a price-to-earnings ratio of 26.39, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The business has a 50-day simple moving average of $32.99 and a two-hundred day simple moving average of $29.34.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business's revenue for the quarter was up 16.3% on a year-over-year basis. During the same period last year, the firm earned $0.26 earnings per share. As a group, research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.